Siltuximab Approved for Rare Blood Disorder

Janssen Biotech on April 23 announced that FDA has approved siltuximab for the treatment of multicentric Castleman disease , a rare blood disorder that affects the lymph nodes.

http://ift.tt/1hpZwwH